论文部分内容阅读
从国家药品监督管理局获悉 ,一种具有国际水平的抗肿瘤新药———威麦宁胶囊 ,继去年在美国进行FDA审批顺利完成”三级跳”后 ,于近日获得国家药准字批文 (准字号为Z2 0 0 10 0 72 ) ,并正式投放国内市场。此举表明 ,有着五千年悠久历史的我国传统中药在实现市场化、国际化
It is learned from the State Drug Administration that a new type of anti-tumor drug with the world-class reputation --- Weimaining Capsule has won the approval of the State Drug Administration recently following the successful completion of the “triple jump” by the FDA in the United States last year Quasi-font size Z2 0 0 10 0 72), and formally put on the domestic market. This shows that with a long history of 5,000 years, traditional Chinese medicine in our market is marketization and internationalization